Jennifer Cocohoba

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies
    Jennifer Cocohoba
    University of California, San Francisco School of Pharmacy, 521 Parnassus Ave, C 152, Box 0622, San Francisco, CA, US 94143 0622
    J Manag Care Pharm 19:454-60. 2013
  2. ncbi request reprint Improved antiretroviral refill adherence in HIV-focused community pharmacies
    Jennifer M Cocohoba
    School of Pharmacy, University of California at San Francisco, 521 Parnassus Ave, San Francisco, CA 94143, USA
    J Am Pharm Assoc (2003) 52:e67-73. 2012
  3. pmc Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART
    Jennifer M Cocohoba
    Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA
    AIDS Care 24:20-9. 2012
  4. doi request reprint Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women
    Jennifer Cocohoba
    Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
    J Acquir Immune Defic Syndr 47:377-83. 2008
  5. doi request reprint Raltegravir: the first HIV integrase inhibitor
    Jennifer Cocohoba
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, California 94143, USA
    Clin Ther 30:1747-65. 2008
  6. doi request reprint The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals
    Jennifer Cocohoba
    Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 521 Parnassus Avenue, C 152, Box 0622, San Francisco, CA 94143, USA
    Expert Rev Anti Infect Ther 7:1159-63. 2009
  7. ncbi request reprint Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients
    Christie A Robinson
    Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco, San Francisco, CA, USA
    J Am Pharm Assoc (2003) 47:613-5. 2007
  8. pmc The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women
    Thomas Yi
    School of Pharmacy, University of California, San Francisco, CA 94122, USA
    J Acquir Immune Defic Syndr 56:253-62. 2011
  9. ncbi request reprint Making sense of side effects
    Jennifer Cocohoba
    School of Pharmacy, University of California, San Francisco, USA
    BETA 23:19-29. 2011
  10. ncbi request reprint A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians
    Cheng Kin Lao
    Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, 521 Parnassus Ave, C 152 Box 0622, San Francisco, CA 94143 0622, USA
    J Natl Med Assoc 103:518-22. 2011

Detail Information

Publications12

  1. ncbi request reprint A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies
    Jennifer Cocohoba
    University of California, San Francisco School of Pharmacy, 521 Parnassus Ave, C 152, Box 0622, San Francisco, CA, US 94143 0622
    J Manag Care Pharm 19:454-60. 2013
    ..Observational studies suggest that HIV-focused pharmacies can improve antiretroviral therapy (ART) refill adherence, but there is a lack of clear documentation about the kind and variability of adherence interventions that are conducted...
  2. ncbi request reprint Improved antiretroviral refill adherence in HIV-focused community pharmacies
    Jennifer M Cocohoba
    School of Pharmacy, University of California at San Francisco, 521 Parnassus Ave, San Francisco, CA 94143, USA
    J Am Pharm Assoc (2003) 52:e67-73. 2012
    ..To determine differences in patient characteristics, antiretroviral therapy (ART) regimen characteristics, and regimen refill adherence for human immunodeficiency virus (HIV)-focused pharmacy (HIV-P) versus traditional pharmacy (TP) users...
  3. pmc Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART
    Jennifer M Cocohoba
    Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA
    AIDS Care 24:20-9. 2012
    ..Monitoring ART quality based on concordance with expert guidelines could improve treatment outcomes in a substantial number of patients...
  4. doi request reprint Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women
    Jennifer Cocohoba
    Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
    J Acquir Immune Defic Syndr 47:377-83. 2008
    ..HIV treatment guidelines define optimal initial antiretroviral therapy (ART)...
  5. doi request reprint Raltegravir: the first HIV integrase inhibitor
    Jennifer Cocohoba
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, California 94143, USA
    Clin Ther 30:1747-65. 2008
    ..Raltegravir is the first integrase inhibitor to be approved by the US Food and Drug Administration for use in antiretroviral treatment- experienced adult patients with viral resistance...
  6. doi request reprint The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals
    Jennifer Cocohoba
    Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 521 Parnassus Avenue, C 152, Box 0622, San Francisco, CA 94143, USA
    Expert Rev Anti Infect Ther 7:1159-63. 2009
    ....
  7. ncbi request reprint Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients
    Christie A Robinson
    Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco, San Francisco, CA, USA
    J Am Pharm Assoc (2003) 47:613-5. 2007
  8. pmc The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women
    Thomas Yi
    School of Pharmacy, University of California, San Francisco, CA 94122, USA
    J Acquir Immune Defic Syndr 56:253-62. 2011
    ..To evaluate the association between enrollment into an AIDS Drug Assistance Program (ADAP) and use of highly active antiretroviral therapy (HAART) and antihypertensive therapy...
  9. ncbi request reprint Making sense of side effects
    Jennifer Cocohoba
    School of Pharmacy, University of California, San Francisco, USA
    BETA 23:19-29. 2011
    ..Others hesitate because medications remind them of their disease. For many, the biggest factor in deciding whether to start ART or change their current regimen is the fear of medication side effects...
  10. ncbi request reprint A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians
    Cheng Kin Lao
    Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, 521 Parnassus Ave, C 152 Box 0622, San Francisco, CA 94143 0622, USA
    J Natl Med Assoc 103:518-22. 2011
    ..Although African Americans are at a higher risk of developing chronic kidney disease, there are limited data examining the influence of race on tenofovir-related nephrotoxicity...
  11. ncbi request reprint Hormonal contraception for HIV positive women
    Jennifer Cocohoba
    School of Pharmacy, University of California, San Francisco, USA
    BETA 22:36-40. 2010
    ....
  12. pmc Potential adverse effects and inferior efficacy in ARV treatment
    Donald Graves
    J Natl Med Assoc 96:692-3; author reply 693. 2004